Correspondence to Jacob Allan Udell, Cardiovascular Division, Department of Medicine, Women’s College Hospital, Women’s College Research Institute, University of Toronto, Toronto ON M5S 1B1, Canada; ...
Correspondence to Aurélien M Guéroult, Department of Surgery & Cancer, Imperial College Healthcare NHS Trust, London, UK; aurelien.gueroult1{at}nhs.net Objective Nickel allergy is common; endovascular ...
Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...
Background Menopause is a timely opportunity to screen for cardiovascular disease (CVD) and intervene with healthier ...
Background There is substantial interest in the cardiovascular effects of e-cigarette use, highlighting the need to update ...
Determining kidney function-specific thresholds for N-terminal pro-B-type natriuretic peptide in heart failure risk prediction among patients with chronic kidney disease: a multicentre, observational, ...
1 Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands 2 Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands Correspondence ...
Background Premature ventricular complexes (PVCs) predict coronary heart disease, heart failure, atrial fibrillation and death, all of which are also related to sodium intake. We studied estimated ...
Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused ...
Background Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback